Understanding the complexities of Parkinson's Disease (PD) is crucial for healthcare professionals. As the second most common neurodegenerative disorder, it presents unique challenges in diagnosis and management.
PD is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to a disruption in the balance of dopamine and acetylcholine. This imbalance results in the cardinal motor symptoms of PD: bradykinesia, tremor, rigidity, and postural instability.
Motor symptoms are often the initial presentation, but non-motor symptoms such as depression, cognitive impairment, and autonomic dysfunction are common. As the disease progresses, motor symptoms may become more prominent and disabling.
Diagnosis is primarily clinical, based on history and physical examination. Neuroimaging, while not routinely used, can support the diagnosis in uncertain cases. Biomarkers are an area of active research but are not currently used in clinical practice.
Treatment is symptomatic and includes pharmacological and non-pharmacological interventions. Levodopa remains the most effective medication for motor symptoms. Non-pharmacological interventions include physical therapy, occupational therapy, and speech therapy.
PD is a progressive disease with variable rates of progression. Factors influencing prognosis include age at onset, severity of symptoms, and presence of comorbidities. While there is currently no cure, treatments can significantly improve quality of life.
In conclusion, PD is a complex neurodegenerative disorder requiring a comprehensive approach to diagnosis and management. As healthcare professionals, it is essential to stay abreast of the latest research and treatment options to provide the best care for our patients.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation